Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Pericapsular Nerve Group (PENG) Block.
- Who it may be relevant to
- Registry conditions: Hip Fractures, Pain, Postoperative. Basic parameters: 30 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of Pericapsular Nerve Group (PENG) Block Applied for Analgesia on the Postoperative Process in Patients Undergoing Hip Fracture Surgery.
Overview
In this study, it was aimed to compare the multimodal analgesia application or the pericapsular nerve group (PENG) block methods in patients undergoing hip surgery. The effectiveness and benefit rate of the PENG block in postoperative pain will be evaluated. Postoperative pain, need for additional analgesia, range of motion of the hip joint, mobilization time, length of hospital time and adverse events in patients undergoing hip fracture surgery with and without PENG block will be investigated.
Detailed description
This prospective randomised controlled study included a total of 70 patients aged 30-85 years who underwent hip fracture surgery under spinal anaesthesia. Patients were randomly divided into two groups using the sealed envelope method, Group I: those who received PENG block (n:35) and Group II:Those who did not receive PENG block (control group) (n: 35).
All patients will undergo hip fracture surgery by the same surgical team. Each patient will be informed about the procedure to be performed during anesthesia and surgery, and signed informed consent will be obtained before the procedure.Patients in Group I who will undergo the PENG block method; Before surgery, after spinal anesthesia, PENG block is performed under sterile conditions under ultrasonography guidance. With the patient supine, a 2-5 MHz, low-frequency, curvilinear probe is placed in the transverse plane medial to the anterior inferior iliac spine (AIIS), with the medial end of the probe rotated approximately 45° counterclockwise to align with the superior pubic ramus.
With the PENG block, an 80 mm block needle is placed in the fascial plane between the psoas tendon and the pubic ramus and 20 ml of 0.5% bupivacaine is administered.
As for the patients in Group II (control group); It is a routine practice at the end of surgery; 10 ml 0.5% bupivacaine + 10 ml 2% lidocaine is infiltrated into the surgical area by the surgical team.
For routine postoperative multimodal analgesia, intravenous PCA (patient controlled analgesia) was administered to patients in both groups with tramadol 50 mg at a basal rate of 10 mg / hour after loading (20 mg bolus dose + 30 minutes lock time) and paracetamol 10 mg / kg iv. (Given every 8 hours)
Interventions
- Procedure Pericapsular Nerve Group (PENG) Block
Pericapsular nerve group (PENG) block The femoral nerve and obturator nerve terminal branches, which provide sensory innervation of the hip joint, are blocked, thus providing analgesia without creating a motor block.
Primary outcome measures
- postoperative pain score [Time frame: 30 min, 12th, 24th and 48th hours in the postoperative period]
- Total opioid consumption [Time frame: postoperative 48 hours]
- mobilisation time [Time frame: postoperative 24-48 hours]
Secondary outcome measures (2)
- PENG block adverse events [Time frame: between the time surgery starts and the 48th hour]
- length of hospital stay [Time frame: between the time of hospitalization for the operation and discharge (day)]
Eligibility criteria
Inclusion criteria
- Patients who will undergo hip fracture surgery Women and men aged 30-85
Exclusion criteria
- Patients under 30 years old, over 85 years old
- American Society of Anesthesiology (ASA) IV,
- Those with cognitive impairment (alzheimer, dementia, delirium, etc.)
- Those with application site infection
- Those who are allergic to local anesthetic substances
- Patients are non-consenting patients.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 2 centers
- Umraniye Education and Research Hospital — Istanbul
- UmraniyeERH — Istanbul
Identifiers
NCT: NCT06183541 · UERH-AR-ZT-03